Printer Friendly

Evaluating a Drug to Prevent Fatal Blood Clots

Cats with heart disease often die of blood clots. This study evaluates a new orally administered anticlotting drug, rivaroxaban, which has shown promise in treating people with heart disease. Identification of a drug that could effectively and safely prevent blood clots in cats would significantly improve outcomes for cats with heart disease.

D13FE-304
Dr. Gregg Rapoport, University of Georgia, First Award